AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)
AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand name including Rybrevant Faspro. Available dosage form: injection.
Drug details
- Generic Name
- AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)
- Brand Names
- Rybrevant Faspro
- Application Number
- BLA761433
- Sponsor
- Janssen Biotech, Inc.
- NDC Codes
- 12
- Dosage Forms
- INJECTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- AMIVANTAMAB, HYALURONIDASE (HUMAN RECOMBINANT)